BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20386493)

  • 1. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.
    Stamp LK; Chapman PT; O'Donnell JL; Zhang M; James J; Frampton C; Barclay ML; Kennedy MA; Roberts RL
    Pharmacogenet Genomics; 2010 Jun; 20(6):367-76. PubMed ID: 20386493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
    Dervieux T; Greenstein N; Kremer J
    Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis.
    Weisman MH; Furst DE; Park GS; Kremer JM; Smith KM; Wallace DJ; Caldwell JR; Dervieux T
    Arthritis Rheum; 2006 Feb; 54(2):607-12. PubMed ID: 16447238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
    Wessels JA; Kooloos WM; De Jonge R; De Vries-Bouwstra JK; Allaart CF; Linssen A; Collee G; De Sonnaville P; Lindemans J; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of folate-related genetic factors in the determination of birthweight.
    Relton CL; Pearce MS; Burn J; Parker L
    Paediatr Perinat Epidemiol; 2005 Sep; 19(5):360-7. PubMed ID: 16115288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
    Schmeling H; Biber D; Heins S; Horneff G
    J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
    Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A
    Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
    Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in folate pathway genes as modulators of genetic instability and lung cancer risk.
    Piskac-Collier AL; Monroy C; Lopez MS; Cortes A; Etzel CJ; Greisinger AJ; Spitz MR; El-Zein RA
    Genes Chromosomes Cancer; 2011 Jan; 50(1):1-12. PubMed ID: 20842733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.
    de Jonge R; Hooijberg JH; van Zelst BD; Jansen G; van Zantwijk CH; Kaspers GJ; Peters GJ; Ravindranath Y; Pieters R; Lindemans J
    Blood; 2005 Jul; 106(2):717-20. PubMed ID: 15797993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease.
    Brooks AJ; Begg EJ; Zhang M; Frampton CM; Barclay ML
    Ther Drug Monit; 2007 Oct; 29(5):619-25. PubMed ID: 17898653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.